PER-106-06已完成未知
A Study to Evaluate the Efficacy of Quadrivalent HPV Vaccine in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related CIN, AIS, and Cervical Cancer, and HPV 6-, 11-, 16-, and 18-Related External Genital Warts, Vulvar Intraepithelial Neoplasia Vaginal Intraepithelial Neoplasia, Vulvar Cancer, and Vaginal Cancer in 16- to 23-Year-Old Women- The F.U.T.U.R.E. study
MERCK SHARP & DOHME PERU S.R.L.,0 个研究点目标入组 0 人开始时间: 2007年1月5日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 0 至 0（—）
入选标准
- •Consult the individual protocol of the substudies (V501-011, V501-012) to see the inclusion criteria in the randomization of the study.
排除标准
- •Consult the individual protocol of the substudies (V501-011, V501-012) to see the exclusion criteria in the randomization of the study.
研究者
相似试验
进行中（未招募）
1 期
A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16, and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related Anogenital Warts, and the Incidence of HPV 6-, 11-, 16-, and 18-Related Genital Infection in 16- to 23-Year-Old Men - HPV Vaccine Efficacy Study in Young MePrevention of Human Papillomavirus InfectionsMedDRA version: 7.0Level: LLTClassification code 10063001EUCTR2004-002945-10-DEMerck & Co., Inc2,020
进行中（未招募）
1 期
A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16, and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related Anogenital Warts, and the Incidence of HPV 6-, 11-, 16-, and 18-Related Genital Infection in 16- to 23-Year-Old Men - HPV Vaccine Efficacy Study in Young MePrevention of Human Papillomavirus InfectionsMedDRA version: 7.0Level: LLTClassification code 10063001EUCTR2004-002945-10-FISuomen MSD OY2,700
进行中（未招募）
不适用
A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16,and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-,11-, 16-, and 18-Related Anogenital Warts, and the Incidence of HPV 6-,11-, 16-, and 18-Related Genital Infection in 16- to 23-Year-Old MePrevention of Human Papillomavirus InfectionsMedDRA version: 14.0Level: LLTClassification code 10063001Term: Human papilloma virus infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2004-002945-10-Outside-EU/EEAMerck Sharp & Dohme (Sweden) AB4,040
进行中（未招募）
1 期
A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16, and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related Anogenital Warts, and the Incidence of HPV 6-, 11-, 16-, and 18-Related Genital Infection in 16- to 23-Year-Old Men - HPV Vaccine Efficacy Study in Young MePrevention of Human Papillomavirus InfectionsMedDRA version: 7.0Level: LLTClassification code 10063001EUCTR2004-002945-10-ESMerck & Co. Inc.2,700
进行中（未招募）
1 期
A Study to Evaluate the Efficacy of Quadrivalent HPV (Types 6, 11, 16, and 18) L1 Virus-Like Particle (VLP) in Reducing the Incidence of HPV 6-, 11-, 16-, and 18-Related Anogenital Warts, and the Incidence of HPV 6-, 11-, 16-, and 18-Related Genital Infection in 16- to 23-Year-Old Men - HPV Vaccine Efficacy Study in Young MePrevention of Human Papillomavirus InfectionsMedDRA version: 7.0Level: LLTClassification code 10063001EUCTR2004-002945-10-SEMerck Sharp & Dohme (Sweden) AB4,040